Searched for
JAPANESE DRUGMAKER
Molecule glue drugs shake up cancer care, draw big moneyHarvard-born idea doubles survival in trials, triggers pharma frenzy as cos race to target 'undruggable' proteins with next-gen glue therap...- Despite litigation, IHH says it is focused on key milestones for FortisMalaysia-based hospital operator IHH Healthcare has reached out to its largest shareholder Mitsui & Co. to help open communication with Jap...
- Global Markets | Japan's Nikkei falls as US-Iran tensions unsettle investorsJapan's Nikkei share average fell on Friday as heightened U.S.-Iran tensions and a sell-off in U.S. private-equity shares dented sentiment.
- TrumpRx: Japanese drugmakers slump after Trump unveils discount drug websiteShares of Japanese pharmaceutical companies fell sharply in early Tokyo trading after the launch of TrumpRx, a U.S. website offering discou...
- Japan's Takeda in regulatory talks to launch dengue vaccine in IndiaThe Japanese drugmaker plans to scale up the production of its dengue vaccine Qdenga through a partnership with Indian vaccine maker Biolog...
- Japan stocks end lower as dour earnings hit construction firmsThe Nikkei share average fell 0.35% to 29,507.05, despite Wall Street finishing strong on Friday, slipping from a one-month high hit on Thu...
- Pfizer applies for COVID-19 vaccine approval in JapanDrugmaker Pfizer Inc said on Friday it had applied for approval in Japan for its COVID-19 vaccine, which is already being administered in t...
- Dr Reddy's launches antiviral drug Avigan in India, to launch remdesivir in SeptemberIndian generic drug maker Dr Reddy's Laboratories on Wednesday announced the launch of antiviral drug Avigan (favipiravir) tablets, current...
- Daiichi Sankyo spreading falsehood: FortisET reported on March 19 that Daiichi had written to ED seeking an investigation on allegations that the Singh brothers siphoned off money f...
- Hold Daiichi for contempt of court responsible for leak: RH HoldingsThe company’s statement came in the wake of a news report that said Ranbaxy’s promoters duped Japanese drugmaker Diiachi Sankyo by withhold...
- Lupin in talks with Japan's Astellas, Shionogi to buy their off-patent drug brandsThe acquisition will result in a wider offering for Lupin in Japanese market where its sales last fiscal stood at Rs 1,364 crore.
- Rs 2,000 crore Novartis deal to help Sun Pharma rise in JapanThe discussions between Sun Pharma and Novartis, according to people privy to the matter, pertain to hiving off a handful of older products.
- Japan's Daiichi Sankyo set to sell its entire 9% stake in Sun Pharma for Rs 18,000 croreDaiichi Sankyo will exit from Sun Pharma by selling its 9% stake it owns in it for Rs 18,000 crore in block trades in the stock market.
- Not just MNCs, local cash-rich pharma companies also take to deal streetMultinational firms have been usually acquiring Indian drugmakers to expand in the country and leverage their manufacturing facilities.
- Daiichi Sankyo contests Andhra Pradesh High Court fiat on Ranbaxy dealHC had directed BSE and NSE not to approve merger of Sun Pharma and Ranbaxy, while admitting a petition alleging insider trading in the $4-...
- Daiichi's open offer for Zenotech to start from Aug 4Zenotech Laboratories today said the open offer by Japanese drugmaker Daiichi Sankyo to acquire 20 per cent stake in it will start from Aug...
- Ranbaxy loses out on FDA delayRanbaxy, the Indian unit of Japanese drugmaker Daiichi Sankyo, was to launch the generic version of the Japan-based Astellas’ Flomax on Mar...
- FIPB rejects Zenotech plea against DaiichiThe country’s foreign investment regulator has rejected a plea by Zenotech Laboratories seeking the withdrawal of its earlier ruling that a...
- Ranbaxy cuts pay package to one-third for new chiefThe country's top drugmaker, Ranbaxy, has proposed an annual pay package of Rs 6 crore for its new CEO and MD Atul Sobti, but his remunerat...
- Daiichi's open offer to buy 20% in Zenotech hits SAT hurdleSAT, the apex body for corporate disputes in the country, on Friday prevented Japan’s Daiichi Sankyo from making an open offer to buy a 20%...
Load More
